13F Holdings
中文EN

SLSN SOLESENCE, INC.

Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 883107 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.0%
TTM net income YoY364.7%
TTM EPS YoY1,152,921,504,606,847,232.0%
Revenue 3-yr CAGR17.5%
Net income 3-yr CAGR—

Margins

Gross margin31.7%
Operating margin6.0%
Net margin4.5%
FCF margin—
EBITDA margin8.0%

Returns

ROE18.2%
ROA5.8%
ROIC (approx.)25.8%
Asset turnover1.29x

Leverage & solvency

Liabilities / assets62.3%
Debt / equity0.00x
Current ratio1.73x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.72x
Accruals ratio-15.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$62.06M$52.35M$37.30M$37.32M$29.48M
Cost of revenue$44.98M$39.30M$30.02M$28.96M$20.79M
Gross profit$17.08M$13.05M$7.28M$8.36M$8.69M
R&D expense$4.09M$3.84M$3.84M$3.04M$2.23M
SG&A expense$10.40M$7.22M$7.53M$7.58M$3.90M
Operating income$2.59M$2.00M-$4.09M-$2.26M$2.56M
Interest expense—$670,000$838,000$382,000$1.15M
Pretax income$2.88M$1.33M-$4.93M-$2.64M$2.36M
Income tax$73,000$227,000$6,000-$17,000$37,000
Net income$2.81M$1.10M-$4.94M-$2.62M$2.32M
EBITDA$3.49M$2.92M-$3.17M-$1.69M$3.01M
EPS (basic)0.040.02-0.10-0.050.05
EPS (diluted)0.040.02-0.10-0.050.05
Weighted avg. shares (diluted)72.58M65.03M49.56M49.12M47.04M
Balance sheet
Cash & equivalents$1.29M$1.41M$1.72M$2.19M$657,000
Receivables$6.84M$4.87M$3.47M$4.73M$3.94M
Inventory$14.88M$15.62M$8.52M$8.84M$6.09M
Current assets$25.14M$24.70M$14.79M$16.62M$11.60M
PP&E, net$14.33M$12.73M$8.67M$7.95M$4.71M
Total assets$46.42M$45.35M$31.37M$33.56M$28.39M
Current liabilities$13.93M$25.77M$15.59M$13.84M$7.34M
Long-term debt———$1.00M$1.00M
Total debt———$1.00M$1.00M
Total liabilities$32.42M$35.06M$30.98M$28.88M$20.93M
Shareholders' equity$14.00M$10.29M$387,000$4.68M$7.46M
Net debt———-$1.19M$343,000
Shares outstanding70.61M70.10M49.63M49.32M48.89M
Cash flow statement
Operating cash flow-$8.57M$1.97M-$2.01M-$1.65M$2.32M
Capital expenditure—$4.56M$1.05M$2.82M$1.87M
Free cash flow—-$2.59M-$3.06M-$4.47M$447,000
Investing cash flow-$2.14M-$4.56M-$1.05M-$2.82M-$1.87M
Financing cash flow$10.59M$2.27M$2.59M$6.00M-$747,000
Depreciation & amortization$897,000$928,000$918,000$567,000$454,000
Stock-based compensation$575,000$725,000$773,000$625,000$160,000

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.